<DOC>
	<DOCNO>NCT00090649</DOCNO>
	<brief_summary>To compare antidepressant efficacy safety DVS-233 SR placebo adult outpatient MDD .</brief_summary>
	<brief_title>Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Men woman 18 75 year age , inclusive . Sexually active individual participate study must use medically acceptable form contraception study least 15 day last dose test article Subjects must primary diagnosis major depressive disorder Treatment DVS233 SR time past Treatment venlafaxine ( immediate release [ IR ] extend release [ ER ] ) within 90 day study day 1 Known hypersensitivity venlafaxine ( IR ER )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>